Grant: CIHR Fellowship
Direct Payment
$100,000.00
Transport of drugs across the blood-brain barrier using surface-engineered cellulose nanocrystals
EF 2014-15
Résumé
More than 100 years ago it was discovered that if blue dye was injected into the bloodstream of an animal, tissues of the whole body would turn blue, except for the brain and spinal cord. This is due to the presence of a semi-permeable barrier, known as the blood-brain barrier (BBB), which protects the central nervous system from potentially harmful chemicals. Very few medications can reach the brain when administered through the blood stream, mainly due to the presence of this barrier. When possible, e.g., following the removal of a brain tumor, therapeutic agents are applied directly to the brain tissue. This method is not ideal, because it is hard to dose chemotherapeutic agents high enough to sufficiently penetrate the tissue to be effective and low enough to be safe for the patient and healthy tissue. A promising way to deliver sufficient doses of drugs to the brain is the employment of biodegradable polymeric nanoparticles as drug carriers. However, not all nanocarriers are successful and the surface properties of the nanoparticle must be carefully engineered to allow the particle to pass the barrier between blood capillaries and brain cells and spread deeply into the brain tissue.
Cellulose nanocrystals (CNCs) are the elementary building blocks of trees and plants and are therefore non-toxic and completely safe for injecting into our body. They fully degrade inside our bodies within days and thus do not accumulate in our liver and spleen like most high performing drug delivery nanocarriers. CNCs have the optimal size for cell internalization, and their elongated morphology offers an important advantage for avoiding clearance by host immune system. The aim of this project is to develop a novel nanocarrier based on CNCs for drug delivery to brain tissue and to investigate their performance using novel microchips and 3D tissue culture tools. These nanocarriers are also promising candidates for brain imaging and can help us understand how our brain functions.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
318923
Name
Hosseinidoust Zeinab
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Transport of drugs across the blood-brain barrier using surface-engineered cellulose nanocrystals
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Biodegradable Nanovehicles; Blood-Brain Barrier; Cellulose Nanocrystals; Nano Drug Delivery
Abstract
More than 100 years ago it was discovered that if blue dye was injected into the bloodstream of an animal, tissues of the whole body would turn blue, except for the brain and spinal cord. This is due to the presence of a semi-permeable barrier, known as the blood-brain barrier (BBB), which protects the central nervous system from potentially harmful chemicals. Very few medications can reach the brain when administered through the blood stream, mainly due to the presence of this barrier. When possible, e.g., following the removal of a brain tumor, therapeutic agents are applied directly to the brain tissue. This method is not ideal, because it is hard to dose chemotherapeutic agents high enough to sufficiently penetrate the tissue to be effective and low enough to be safe for the patient and healthy tissue. A promising way to deliver sufficient doses of drugs to the brain is the employment of biodegradable polymeric nanoparticles as drug carriers. However, not all nanocarriers are successful and the surface properties of the nanoparticle must be carefully engineered to allow the particle to pass the barrier between blood capillaries and brain cells and spread deeply into the brain tissue.
Cellulose nanocrystals (CNCs) are the elementary building blocks of trees and plants and are therefore non-toxic and completely safe for injecting into our body. They fully degrade inside our bodies within days and thus do not accumulate in our liver and spleen like most high performing drug delivery nanocarriers. CNCs have the optimal size for cell internalization, and their elongated morphology offers an important advantage for avoiding clearance by host immune system. The aim of this project is to develop a novel nanocarrier based on CNCs for drug delivery to brain tissue and to investigate their performance using novel microchips and 3D tissue culture tools. These nanocarriers are also promising candidates for brain imaging and can help us understand how our brain functions.
Competitiondate
201411
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Hosseinidoust, Zeinab
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $100,000~ $0~